Hot Topics in Adult Immunization, 2014

Sandra Adamson Fryhofer, MD


November 18, 2014

In This Article
Sandra Adamson Fryhofer, MD
Adjunct Associate Professor of Medicine, Emory University School of Medicine, Atlanta, Georgia; Past President, American College of Physicians

Hot Topics in Adult Immunization

This issue of Staying Well focuses on hot topics in adult immunization and is inspired by IDWeek 2014, the combined annual meeting of an alphabet soup of infectious diseases organizations: IDSA (Infectious Diseases Society of America), SHEA (Society for Healthcare Epidemiology of America), HIVMA (HIV Medicine Association), and PIDS (Pediatric Infectious Diseases Society).

As the American College of Physicians' adult immunization liaison to ACIP (Advisory Committee on Immunization Practices), I was asked to update this esteemed group of attendees—researchers, clinicians, quality and patient safety practitioners, epidemiologists, and public health officials—on hot topics in adult immunization at the 2014 meeting in Philadelphia.[1]

As we review what's hot, remember that ACIP recommendations are now evidence-based using the GRADE (Grading of Recommendations Assessment, Development and Evaluation)protocol. ACIP recommendations do not become official until published in the Centers for Disease Control and Prevention's (CDC's) MMWRMorbidity and Mortality Weekly Report and are not always consistent with the US Food and Drug Administration's (FDA's) licensing parameters—a fact that is often confusing for practitioners.[2]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.